http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2388237-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
filingDate 2000-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a189a31aeac311e2d583475c4cfb004b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efd864e3e76fc5d61afd4986fa2ba464
publicationDate 2001-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2388237-A1
titleOfInvention Treatment of osteoporosis
abstract The present invention relates to a method for the prevention or treatment of postmenopausal osteoporosis by initiating the treatment with a low dose of a n estrogenic compound and increasing the dose of the estrogenic compound after the initiation period.
priorityDate 1999-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535674

Total number of triples: 20.